Hypoxia-inducible factor 1alpha expression as an intrinsic marker of hypoxia: correlation with tumor oxygen, pimonidazole measurements, and outcome in locally advanced carcinoma of the cervix.
about
Hypoxia and metabolic adaptation of cancer cellsElevated CAIX Expression is Associated with an Increased Risk of Distant Failure in Early-Stage Cervical CancerMarkers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group studyClinical biomarkers for hypoxia targetingCandidate biomarkers for cervical cancer treatment: Potential for clinical practice (Review).In vivo observation of intracellular oximetry in perfluorocarbon-labeled glioma cells and chemotherapeutic response in the CNS using fluorine-19 MRI.Angiogenesis and antiangiogenic agents in cervical cancer.Primary tumor vascularity, HIF-1α and VEGF expression in vulvar squamous cell carcinomas: their relationships with clinicopathological characteristics and prognostic impact.Proline-hydroxylated hypoxia-inducible factor 1α (HIF-1α) upregulation in human tumours.Regulatory Effects of microRNA-92 (miR-92) on VHL Gene Expression and the Hypoxic Activation of miR-210 in Clear Cell Renal Cell Carcinoma.Clinicopathological characteristics of gynecological cancer associated with hypoxia-inducible factor 1α expression: a meta-analysis including 6,612 subjects.A potentially common peptide target in secreted heat shock protein-90α for hypoxia-inducible factor-1α-positive tumors.Hypoxia biomarkers in squamous cell carcinoma of the uterine cervix.Hypoxia stabilizes GAS6/Axl signaling in metastatic prostate cancer.Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients.Hypoxia-inducible factor-1alpha expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomasNo relationship between thymidine phosphorylase (TP, PD-ECGF) expression and hypoxia in carcinoma of the cervixMicroregional antitumor activity of a small-molecule hypoxia-inducible factor 1 inhibitorInsights towards sulfonamide drug specificity in α-carbonic anhydrasesExpression of VEGF and HIF-1α in locally advanced cervical cancer: potential biomarkers for predicting preoperative radiochemotherapy sensitivity and prognosisPhotodynamic therapy for treatment of solid tumors--potential and technical challenges.Imaging and analytical methods as applied to the evaluation of vasculature and hypoxia in human brain tumors.Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry.Predicting response to clinical radiotherapy: past, present, and future directions.Immunohistochemical detection of changes in tumor hypoxiaOxygen-mediated endocytosis in cancer.Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies.Reengineering the Tumor Microenvironment to Alleviate Hypoxia and Overcome Cancer Heterogeneity.Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis.Update on carbonic anhydrase inhibitors: a patent review (2008 - 2011).Hypoxia in cervical cancer: from biology to imaging.Delta-like ligand 4-notch blockade and tumor radiation response.Lister strain vaccinia virus, a potential therapeutic vector targeting hypoxic tumours.Correlation of volumetric perfusion CT parameters with hypoxia inducible factor-1 alpha expression in a rabbit VX2 tumor model.The prognostic value of expression of HIF1α, EGFR and VEGF-A, in localized prostate cancer for intermediate- and high-risk patients treated with radiation therapy with or without androgen deprivation therapyClinical significance of HIF-2α immunostaining area in radioresistant cervical cancer.Measurements of hypoxia ([(18)F]-FMISO, [(18)F]-EF5) with positron emission tomography (PET) and perfusion using PET ([(15)O]-H(2)O) and power Doppler ultrasonography in feline fibrosarcomas*.Past, Present, and Future: Development of Theranostic Agents Targeting Carbonic Anhydrase IX.BMPR2 and HIF1-α overexpression in resected osteosarcoma correlates with distant metastasis and patient survival.Glut-1 expression in small cervical biopsies is prognostic in cervical cancers treated with chemoradiation.
P2860
Q26774856-79703FBF-E4F8-4359-A472-E358DF3A01A0Q28250852-412DDA04-961D-4944-8DD3-9BE5F775D3ADQ30436395-C5C3D9D8-CE3B-4D0B-AAF6-240C6708B617Q33714638-08E90703-A572-4897-9131-353B2BBC31D1Q33933054-2787455B-E598-41CF-AEC3-413A68A46C5BQ34249620-C658D7E9-681F-4918-8298-164B9917F10AQ34655335-4EEE6D9C-1BEA-4BAA-85AD-71846FC8F9BDQ35027303-2E3196BD-E8E5-4933-8085-ED7478B4085AQ35101075-D5BFAAFB-3ECC-4617-9C48-A97DE89D5D84Q35479824-F945C162-4AF7-4696-9B14-07F53D2544BDQ35625509-0E57932A-6E35-4F0D-B8BA-47558D6A8876Q35756686-A1A33172-0AB1-4BB5-BD54-472F035E40BEQ35821578-16E2F87D-1DBA-45F6-8C43-CA1F26A961B4Q36044487-4D266370-ABB9-4354-BE29-E836A06ED30CQ36306066-F41B2620-A7CD-4CA5-8788-FF2F0266A901Q36610552-0C4A3E48-F62A-4D70-BEE6-FD0B19CBCDECQ36613493-67902A8E-1D12-4EB0-8EE4-82F907E6D2BDQ36623493-B5E39876-A245-4A0A-9772-84DD0615F1C3Q36673491-A00F8EDD-1F12-415C-9D6B-146D978C2E47Q36944132-64A31758-2C07-406E-894D-0E22DCEF3EFBQ36995497-1DBA6689-408C-4E62-B54E-D504AF705265Q37068806-432D3FA9-AD05-4A3E-89D5-23F0B8132B2CQ37113797-728B9879-8DDF-4E2C-A3F3-6324BC7A4DF1Q37123131-59A46B29-A157-4CFF-A6E1-819C81DAD8B3Q37188441-4B8C50A5-B4DC-4F5C-8AC9-6F25D619E429Q37296289-4C831CD2-B7E8-4335-AD3A-B6500A10652EQ37426436-EB055B70-5D2B-4FE5-B068-1602FE9DCFC6Q37461422-24144B2B-D6DC-4D07-9F23-E727434D2380Q37617542-2BD96FE5-8CAD-4954-B207-9906DC2CB339Q38025742-CF31E7C2-C24B-4FEA-9B9C-C4A115221AFBQ38643119-D0DDCB5F-0A42-4483-BBDD-F2D94463BCE1Q39456092-9FE5E6EF-0CBB-433E-A5C6-C5E586112A7AQ39778777-654996A6-46C6-4C6B-A4CB-AAD9959722F2Q40575060-00775B99-F92D-44AD-880C-F536EE83862DQ41839517-7C5EEF56-38C9-49D4-A423-3F2A27ADC971Q41841034-8ADD4D3A-60D2-4F21-89BE-355FC069BBE1Q43276498-2A8DB109-DA21-4D2D-B3F6-B218B7BF27DFQ47097799-56799F4A-C96C-4A21-A36B-07B01101966AQ47137400-3C5036E1-338D-471C-8B06-05AE88A9B9E3Q52794306-AE22E0BB-1077-4D68-AAF4-00F5676BCF0F
P2860
Hypoxia-inducible factor 1alpha expression as an intrinsic marker of hypoxia: correlation with tumor oxygen, pimonidazole measurements, and outcome in locally advanced carcinoma of the cervix.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Hypoxia-inducible factor 1alph ...... anced carcinoma of the cervix.
@en
type
label
Hypoxia-inducible factor 1alph ...... anced carcinoma of the cervix.
@en
prefLabel
Hypoxia-inducible factor 1alph ...... anced carcinoma of the cervix.
@en
P2093
P50
P1476
Hypoxia-inducible factor 1alph ...... vanced carcinoma of the cervix
@en
P2093
Gillian J Hutchison
Helen R Valentine
Juliette A Loncaster
Patricia M Price
Robert D Hunter
P304
P356
10.1158/1078-0432.CCR-03-0135
P407
P577
2004-12-01T00:00:00Z